On April 14, 2022, the FDA released draft guidance that aims to diversify the population of participants in clinical trials.…
Read More
In 2015, NIH solicited public input on an agency-wide strategic plan framework for the subsequent five years in response to…
Read MoreOn November 8, 2019, the National Institutes of Health (NIH) released its Draft NIH Policy for Data Management and Sharing…
Read MoreThe Office for Civil Rights (OCR) within the Department of Health and Human Services (HHS) recently put out a "Request…
Read MorePRIM&R recently submitted comments in response to the Food and Drug Administration (FDA)’s proposed rule "Institutional Review Board Waiver or…
Read More